Atsuko Hachiya

1.9k total citations
58 papers, 1.1k citations indexed

About

Atsuko Hachiya is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Atsuko Hachiya has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Virology, 49 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Atsuko Hachiya's work include HIV Research and Treatment (50 papers), HIV/AIDS drug development and treatment (47 papers) and HIV/AIDS Research and Interventions (24 papers). Atsuko Hachiya is often cited by papers focused on HIV Research and Treatment (50 papers), HIV/AIDS drug development and treatment (47 papers) and HIV/AIDS Research and Interventions (24 papers). Atsuko Hachiya collaborates with scholars based in Japan, United States and Vietnam. Atsuko Hachiya's co-authors include Shinichi Oka, Stefan G. Sarafianos, Hiroyuki Gatanaga, Karen A. Kirby, Hirotaka Ode, Eiichi Kodama, Yasumasa Iwatani, Yoshiyuki Yokomaku, Eleftherios Michailidis and Kamalendra Singh and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Atsuko Hachiya

55 papers receiving 1.1k citations

Peers

Countries citing papers authored by Atsuko Hachiya

Since Specialization

Citations

This map shows the geographic impact of Atsuko Hachiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Hachiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Hachiya more than expected).

Fields of papers citing papers by Atsuko Hachiya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Hachiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Hachiya. The network helps show where Atsuko Hachiya may publish in the future.

Co-authorship network of co-authors of Atsuko Hachiya

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuko Hachiya. A scholar is included among the top collaborators of Atsuko Hachiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuko Hachiya. Atsuko Hachiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural, biophysical, and virological mechanistic characterization of HIV-1 capsid-targeting antivirals 2025 ·bioRxiv (Cold Spring Harbor Laboratory) ·Karen A. Kirby, (unknown), (unknown), (unknown), Hu Zhang, (unknown), (unknown), (unknown), (unknown), Atsuko Hachiya, (unknown), (unknown), (unknown), (unknown), Philip R. Tedbury, Ashwanth C. Francis, Gregory B. Melikyan, (unknown), (unknown), (unknown), (unknown)	0
2	Evaluation of the Geenius HIV 1/2 confirmatory assay for HIV-2 samples isolated in Japan 2022 ·Journal of Clinical Virology ·(unknown), (unknown), Masakazu Matsuda, (unknown), (unknown), Shiro Ibe, Michiko Nemoto, (unknown), (unknown), Mayumi Imahashi, Tadashi Kikuchi, Wataru Sugiura, Yasumasa Iwatani, Atsuko Hachiya, Yoshiyuki Yokomaku	1
3	Nanopore Sequencing for Characterization of HIV-1 Recombinant Forms 2022 ·Microbiology Spectrum ·(unknown), Hirotaka Ode, (unknown), Yoshihiro Nakata, (unknown), (unknown), (unknown), Masakazu Matsuda, Kazuhiro Matsuoka, Atsuko Sugimoto, Atsuko Hachiya, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani	7
4	Novel HIV-1 capsid-targeting small molecules of the PF74 binding site 2020 ·European Journal of Medicinal Chemistry ·Lei Wang, Mary C. Casey, Sanjeev Kumar V. Vernekar, Rajkumar Lalji Sahani, Jayakanth Kankanala, Karen A. Kirby, Haijuan Du, Atsuko Hachiya, Huanchun Zhang, Philip R. Tedbury, Jiashu Xie, Stefan G. Sarafianos, Zhengqiang Wang	19
5	Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia 2018 ·Scientific Reports ·Michiko Nemoto, Hiroyoshi Hattori, Naoko Maeda, (unknown), Hideki Muramatsu, Suzuko Moritani, Tomonori Kawasaki, (unknown), Hirotaka Ode, Atsuko Hachiya, Wataru Sugiura, Yoshiyuki Yokomaku, Keizo Horibe, Yasumasa Iwatani	27
6	Mapping Region of Human Restriction Factor APOBEC3H Critical for Interaction with HIV-1 Vif 2017 ·Journal of Molecular Biology ·(unknown), Shinya Tsuzuki, (unknown), (unknown), Ayaka Okada, Hirotaka Ode, (unknown), Atsuko Hachiya, Yoshiyuki Yokomaku, Nobuhisa Watanabe, Hirofumi Akari, Yasumasa Iwatani	19
7	Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations 2016 ·Journal of Antimicrobial Chemotherapy ·Tsunefusa Hayashida, Atsuko Hachiya, Hirotaka Ode, Takeshi Nishijima, K. Tsuchiya, Wataru Sugiura, Masafumi Takiguchi, Shinichi Oka, Hiroyuki Gatanaga	7
8	Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance 2016 ·Frontiers in Microbiology ·(unknown), Hirotaka Ode, Koji Suzuki, Masayuki Fujino, (unknown), (unknown), (unknown), Junko Hattori, Masakazu Matsuda, Atsuko Hachiya, Yoshiyuki Yokomaku, Atsuo Suzuki, Nobuhisa Watanabe, Wataru Sugiura, Yasumasa Iwatani	14
9	A Novel Drug-Resistant HIV-1 Circulating Recombinant Form CRF76_01B Identified by Near Full-Length Genome Analysis 2015 ·AIDS Research and Human Retroviruses ·Satoko Ogawa, Atsuko Hachiya, (unknown), Masakazu Matsuda, Hirotaka Ode, (unknown), (unknown), Kenji Sadamasu, Mami Nagashima, Takao Toyokawa, Masao Tateyama, Yasuhito Tanaka, Wataru Sugiura, Yoshiyuki Yokomaku, Yasumasa Iwatani	8
10	HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan 2015 ·AIDS Research and Human Retroviruses ·(unknown), Seiichiro Fujisaki, (unknown), Junko Hattori, Teiichiro Shiino, Hiroyuki Gatanaga, (unknown), (unknown), Atsuko Hachiya, Masakazu Matsuda, Shiro Ibe, Yasumasa Iwatani, Yoshiyuki Yokomaku, Wataru Sugiura, (unknown)	8
11	Quasispecies Analyses of the HIV-1 Near-full-length Genome With Illumina MiSeq 2015 ·Frontiers in Microbiology ·Hirotaka Ode, Masakazu Matsuda, Kazuhiro Matsuoka, Atsuko Hachiya, Junko Hattori, (unknown), Yoshiyuki Yokomaku, Yasumasa Iwatani, Wataru Sugiura	42
12	Restriction fragment mass polymorphism (RFMP) analysis based on MALDI-TOF mass spectrometry for detecting antiretroviral resistance in HIV-1 infected patients 2013 ·Clinical Microbiology and Infection ·(unknown), (unknown), Atsuko Hachiya, (unknown), (unknown), (unknown), Hiroyuki Gatanaga, Shinichi Oka, Karen A. Kirby, Yee Tsuey Ong, Stefan G. Sarafianos, William R. Folk, Won Sang Yoo, Sun Pyo Hong, (unknown)	6
13	Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA 2013 ·Retrovirology ·Eleftherios Michailidis, Emily Ryan, Atsuko Hachiya, Karen A. Kirby, Bruno Marchand, Maxwell D. Leslie, Andrew D. Huber, Yee Tsuey Ong, (unknown), Kamalendra Singh, Eiichi Kodama, Hiroaki Mitsuya, Michael A. Parniak, Stefan G. Sarafianos	31
14	Biochemical Mechanism of HIV-1 Resistance to Rilpivirine 2012 ·Journal of Biological Chemistry ·Kamalendra Singh, Bruno Marchand, K. Devendra, Bechan Sharma, Eleftherios Michailidis, Emily Ryan, (unknown), Maxwell D. Leslie, (unknown), Zhe Li, Pieter R. Norden, Atsuko Hachiya, Michael A. Parniak, Hongtao Xu, Mark A. Wainberg, Stefan G. Sarafianos	55
15	HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Non-nucleoside RT Inhibitors 2012 ·Journal of Biological Chemistry ·Atsuko Hachiya, Bruno Marchand, Karen A. Kirby, Eleftherios Michailidis, (unknown), Krzysztof Palczewski, Yee Tsuey Ong, Zhe Li, (unknown), (unknown), Junko Tanuma, Shinichi Oka, Kamalendra Singh, Eiichi Kodama, Stefan G. Sarafianos	9
16	K70Q Adds High-Level Tenofovir Resistance to “Q151M Complex” HIV Reverse Transcriptase through the Enhanced Discrimination Mechanism 2011 ·PLoS ONE ·Atsuko Hachiya, Eiichi Kodama, (unknown), Karen A. Kirby, Eleftherios Michailidis, Yasuko Sakagami, Shinichi Oka, Kamalendra Singh, Stefan G. Sarafianos	25
17	The N348I Mutation at the Connection Subdomain of HIV-1 Reverse Transcriptase Decreases Binding to Nevirapine 2010 ·Journal of Biological Chemistry ·(unknown), Bruno Marchand, Atsuko Hachiya, Eiichi Kodama, Karen A. Kirby, Kamalendra Singh, Stefan G. Sarafianos	32
18	Impact of CRF01_AE-specific polymorphic mutations G335D and A371V in the connection subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on susceptibility to nucleoside RT inhibitors 2010 ·Microbes and Infection ·Junko Tanuma, Atsuko Hachiya, (unknown), Hiroyuki Gatanaga, (unknown), Nguyễn Đức Hiền, Nguyễn Văn Kính, Mitsuo Kaku, Shinichi Oka	16
19	Impact of human leukocyte antigen-B51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance 2010 ·AIDS* ·Hiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, Tsunefusa Hayashida, Hironori Sato, Masafumi Takiguchi, Shinichi Oka	8
20	Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure 2005 ·Virology ·Hiroyuki Gatanaga, Atsuko Hachiya, Satoshi Kimura, Shinichi Oka	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact